Ovarian hyperstimulation: diagnosis and therapy.
The administration of exogenous gonadotropins to induce ovulation is often associated with ovarian hyperstimulation syndrome. The authors discussed the pathophysiological mechanisms involved in such syndrome to suggest a treatment of choice. Moreover the authors reported their related clinical experience carried out on 9 patients suffering from such syndrome. All the patients studied improved 6-19 days after admission and start of treatment (mean 9.5 +/- 4.7 days). The patients were free from pain and general disorders at discharge and at follow up echographic examination revealed a significant reduction in the volume of the ovary.
Cianci
A
A
Chair of Obstetric and Gynaecological Endocrinology, University of Catania, Italy.
Roccasalva
L
L
Agnello
C
C
Riillo
S
S
Palumbo
G
G
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D005260:Female; D006062:Gonadotropins / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D010049:Ovarian Diseases / Q000175:diagnosis* / Q000628:therapy; D010053:Ovary / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects*; D010952:Plasma Substitutes / Q000627:therapeutic use; D013480:Superovulation
D000925:Anticoagulants; D006062:Gonadotropins; D010952:Plasma Substitutes